Abstract:Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making. Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making.

Lineage-determining transcription factor-driven promoters regulate cell type-specific macrophage gene expression

Abstract 5511: Lineage-specific and Shared Cytokine-Sensing Genes Respond Distinctly to the Master Regulator STAT5

Genome-wide profiling of transcribed enhancers during macrophage activation

Gene expression variability across cells and species shapes the relationship between renal resident macrophages and infiltrated macrophages

Tissue-specific transcriptional programming of macrophages controls the microRNA transcriptome targeting multiple functional pathways

Transcriptional repression shapes the identity and function of tissue macrophages

Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment

Myeloid Lineage Choice is Not Controlled by the Pu.1-Gata1 Switch

Discrete regulatory modules instruct hematopoietic lineage commitment and differentiation

The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU.1 and c-Jun

Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters

High-throughput functional analysis of lncRNA core promoters elucidates rules governing tissue specificity

Exploiting dynamic enhancer landscapes to decode macrophage and microglia phenotypes in health and disease

Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation

The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages

Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells

Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages

Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes

Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction

Integrated transcriptomic and metabolomic analysis reveals the metabolic programming of GM-CSF- and M-CSF- differentiated mouse macrophages

Phenotypic and epigenetic approach evaluating human M1 and M2 macrophages (167.9)